Recomienda este artículo a tus amigos:
Targeting the DNA Damage Response for Anti-Cancer Therapy - Cancer Drug Discovery and Development 2018 edition
Targeting the DNA Damage Response for Anti-Cancer Therapy - Cancer Drug Discovery and Development
As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents thatmay have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.
401 pages, 60 Tables, color; 52 Illustrations, color; 28 Illustrations, black and white; IX, 401 p.
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 5 de junio de 2018 |
| ISBN13 | 9783319758343 |
| Editores | Springer International Publishing AG |
| Páginas | 401 |
| Dimensiones | 150 × 220 × 20 mm · 752 g |
| Lengua | Alemán |
| Editor | Curtin, Nicola |
| Editor | Pollard, John |